Cargando…

Changes in healthcare costs and survival in the era of immunotherapy and targeted systemic therapy for melanoma.

Detalles Bibliográficos
Autores principales:	Nguyen, Paul, Bateni, Sarah, Eskander, Antoine, Seung, Soo Jin, Mittmann, Nicole, Chan, Kelvin, Look-Hong, Nicole, Hanna, Timothy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Swansea University 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9644696/ http://dx.doi.org/10.23889/ijpds.v7i3.1828

Ejemplares similares

Changes in Health Care Costs, Survival, and Time Toxicity in the Era of Immunotherapy and Targeted Systemic Therapy for Melanoma
por: Bateni, Sarah B., et al.
Publicado: (2023)

No Overall Survival Difference in the Immunotherapy Era for Rare Subtypes of Melanoma
por: Safi, Mohammed, et al.
Publicado: (2021)

Healthcare and Cancer Treatment Costs of Breast Screening Outcomes among Higher than Average Risk Women
por: Mittmann, Nicole, et al.
Publicado: (2023)

Cost‐effectiveness of second‐line ipilimumab for metastatic melanoma: A real‐world population‐based cohort study of resource utilization
por: Lu, Brandon, et al.
Publicado: (2023)

Healthcare Costs of Metastatic Cutaneous Melanoma in the Era of Immunotherapeutic and Targeted Drugs
por: Leeneman, Brenda, et al.
Publicado: (2020)

Immunotherapy in the Precision Medicine Era: Melanoma and Beyond
por: Su, Mack Y., et al.
Publicado: (2016)

Trends in survival and costs in metastatic melanoma in the era of novel targeted and immunotherapeutic drugs
por: Franken, M.G., et al.
Publicado: (2021)

Real-world comparative effectiveness of second-line ipilimumab for metastatic melanoma: a population-based cohort study in Ontario, Canada
por: Dai, Wei Fang, et al.
Publicado: (2020)

BRAF and MEK inhibitors in the era of immunotherapy in melanoma patients
por: Mackiewicz, Jacek, et al.
Publicado: (2018)

Impact of smoking on health system costs among cancer patients in a retrospective cohort study in Ontario, Canada
por: Isaranuwatchai, Wanrudee, et al.
Publicado: (2019)

Multimodal Treatment of Advanced Mucosal Melanoma in the Era of Modern Immunotherapy
por: Teterycz, Pawel, et al.
Publicado: (2020)

A case report: metastasis of melanoma to the heart in an era of immunotherapy
por: Poulsen, Christian B, et al.
Publicado: (2019)

Intracranial Treatment in Melanoma Patients with Brain Metastasis Is Associated with Improved Survival in the Era of Immunotherapy and Anti-BRAF Therapy
por: Dalmasso, Céline, et al.
Publicado: (2021)

Cost-effective Analysis of Subcutaneous vs Sublingual Immunotherapy From the Payor’s Perspective
por: Hardin, Frances Mei, et al.
Publicado: (2021)

Are tumor size changes predictive of survival for checkpoint blockade based immunotherapy in metastatic melanoma?
por: Wang, Meihua, et al.
Publicado: (2019)

Impact of cancer surgery slowdowns on patient survival during the COVID-19 pandemic: a microsimulation modelling study
por: Parmar, Ambica, et al.
Publicado: (2022)

Role of Anti-PD-1 Antibodies in Advanced Melanoma: The Era of Immunotherapy
por: Sahni, Sakshi, et al.
Publicado: (2018)

Minimization of resource utilization data collected within cost-effectiveness analyses conducted alongside Canadian Cancer Trials Group phase III trials
por: Cheung, Matthew C, et al.
Publicado: (2021)

Does early palliative identification improve the use of palliative care services?
por: Mittmann, Nicole, et al.
Publicado: (2020)

Imaging and physician visits at cancer diagnosis: COVID ‐19 pandemic impact on cancer care
por: Fu, Rui, et al.
Publicado: (2022)

Early survival for patients newly diagnosed with cancer during COVID‐19 in Ontario, Canada: A population‐based cohort study
por: Fu, Rui, et al.
Publicado: (2023)

Using Real-World Data to Determine Health System Costs of Ontario Women Screened for Breast Cancer
por: Mittmann, Nicole, et al.
Publicado: (2022)

Oral healthcare disparities in Canada: filling in the gaps
por: Levy, Ben B., et al.
Publicado: (2022)

Impact of aggressive management and palliative care on cancer costs in the final month of life
por: Cheung, Matthew C., et al.
Publicado: (2015)

Survival in melanoma brain metastases in the era of novel systemic therapies
por: Merola, Joseph P, et al.
Publicado: (2020)

Survival in melanoma in the nordic countries into the era of targeted and immunological therapies
por: Tichanek, Filip, et al.
Publicado: (2023)

Stereotactic radiosurgery for melanoma brain metastases: dose-size response relationship in the era of immunotherapy
por: Yusuf, Mehran, et al.
Publicado: (2021)

Canine melanoma: A review of diagnostics and comparative mechanisms of disease and immunotolerance in the era of the immunotherapies
por: Stevenson, Valentina B., et al.
Publicado: (2023)

The role of lenvatinib in the era of immunotherapy of hepatocellular carcinoma
por: Lee, Matthew Man Pok, et al.
Publicado: (2023)

Rethinking cost-effectiveness in the era of zero healthcare spending growth
por: Arbel, Ronen, et al.
Publicado: (2016)

Cost-Effectiveness of Frontline Treatment for Advanced Renal Cell Carcinoma in the Era of Immunotherapies
por: Li, SiNi, et al.
Publicado: (2021)

Immunotherapy of melanoma
por: Haanen, John B.A.G.
Publicado: (2013)

Melanoma immunotherapy
por: Garg, Abhishek D., et al.
Publicado: (2015)

Immunotherapy of melanoma
por: Lugowska, Iwona, et al.
Publicado: (2018)

Aspirin in the era of immunotherapy
por: Hamada, Tsuyoshi, et al.
Publicado: (2017)

Cholangiocarcinoma in the Era of Immunotherapy
por: Manthopoulou, Eleni, et al.
Publicado: (2023)

The diagnosis, classification, and treatment of sarcoma in this era of artificial intelligence and immunotherapy
por: Crombé, Amandine, et al.
Publicado: (2022)

The Analysis of Trends in Survival for Patients with Melanoma Brain Metastases with Introduction of Novel Therapeutic Options before the Era of Combined Immunotherapy—Multicenter Italian–Polish Report
por: Placzke, Joanna, et al.
Publicado: (2022)

Ipilimumab, a Promising Immunotherapy with Increased Overall Survival in Metastatic Melanoma?
por: Piérard, Gérald E., et al.
Publicado: (2012)

Distant intracranial failure in melanoma brain metastases treated with stereotactic radiosurgery in the era of immunotherapy and targeted agents
por: Acharya, Sahaja, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ta4jnitd476tj0e9p01bmfoud9